| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |